Logo image of OBEL.BR

ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

Europe - EBR:OBEL - BE0003735496 - Common Stock

19.1 EUR
0 (0%)
Last: 10/17/2025, 4:03:50 PM
Fundamental Rating

3

OBEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 6 industry peers in the Wireless Telecommunication Services industry. OBEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. OBEL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

OBEL had positive earnings in the past year.
In the past year OBEL had a positive cash flow from operations.
OBEL had positive earnings in each of the past 5 years.
OBEL had a positive operating cash flow in each of the past 5 years.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

OBEL has a Return On Assets (0.93%) which is in line with its industry peers.
OBEL has a better Return On Equity (3.88%) than 66.67% of its industry peers.
OBEL has a better Return On Invested Capital (3.63%) than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for OBEL is below the industry average of 6.64%.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.89%, OBEL perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of OBEL has declined.
OBEL has a Operating Margin of 7.62%. This is comparable to the rest of the industry: OBEL outperforms 50.00% of its industry peers.
OBEL's Operating Margin has improved in the last couple of years.
OBEL has a better Gross Margin (68.11%) than 100.00% of its industry peers.
OBEL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
The number of shares outstanding for OBEL has been increased compared to 1 year ago.
Compared to 5 years ago, OBEL has more shares outstanding
Compared to 1 year ago, OBEL has an improved debt to assets ratio.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.96, we must say that OBEL is in the distress zone and has some risk of bankruptcy.
OBEL's Altman-Z score of 0.96 is on the low side compared to the rest of the industry. OBEL is outperformed by 66.67% of its industry peers.
OBEL has a debt to FCF ratio of 23.91. This is a negative value and a sign of low solvency as OBEL would need 23.91 years to pay back of all of its debts.
With a Debt to FCF ratio value of 23.91, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.92 is on the high side and indicates that OBEL has dependencies on debt financing.
With a Debt to Equity ratio value of 1.92, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.96
ROIC/WACC0.7
WACC5.23%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.49 indicates that OBEL may have some problems paying its short term obligations.
OBEL's Current ratio of 0.49 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
A Quick Ratio of 0.46 indicates that OBEL may have some problems paying its short term obligations.
OBEL has a Quick ratio of 0.46. This is amonst the worse of the industry: OBEL underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 780.62% over the past year.
The Earnings Per Share has been decreasing by -9.64% on average over the past years.
The Revenue has decreased by -0.39% in the past year.
OBEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.26% yearly.
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%

3.2 Future

The Earnings Per Share is expected to grow by 33.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, OBEL will show a very negative growth in Revenue. The Revenue will decrease by -10.97% on average per year.
EPS Next Y-67.31%
EPS Next 2Y-52.22%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue Next Year3.5%
Revenue Next 2Y2.16%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.83, OBEL can be considered very expensive at the moment.
Based on the Price/Earnings ratio, OBEL is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
OBEL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.29.
OBEL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 31.83
Fwd PE N/A
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of OBEL indicates a somewhat cheap valuation: OBEL is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.64
EV/EBITDA 5.37
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

OBEL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as OBEL's earnings are expected to grow with 33.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-52.22%
EPS Next 3Y33.42%

0

5. Dividend

5.1 Amount

OBEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORANGE BELGIUM

EBR:OBEL (10/17/2025, 4:03:50 PM)

19.1

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)07-24 2025-07-24
Earnings (Next)02-05 2026-02-05/amc
Inst Owners11.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.29B
Analysts77.78
Price Target20.57 (7.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-57.8%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-78.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 31.83
Fwd PE N/A
P/S 0.65
P/FCF 14.64
P/OCF 2.72
P/B 1.34
P/tB N/A
EV/EBITDA 5.37
EPS(TTM)0.6
EY3.14%
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)1.3
FCFY6.83%
OCF(TTM)7.01
OCFY36.72%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexcg growth 3Y-7.87%
ROICexcg growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.96
F-Score7
WACC5.23%
ROIC/WACC0.7
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
EPS Next Y-67.31%
EPS Next 2Y-52.22%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%
Revenue Next Year3.5%
Revenue Next 2Y2.16%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%
EBIT growth 1Y12.37%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year293.19%
EBIT Next 3Y57.64%
EBIT Next 5Y21.59%
FCF growth 1Y116.96%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y24.22%
OCF growth 3Y10.98%
OCF growth 5Y8.17%